# Aligos Therapeutics, Inc.: Form DEF 14A, filed Apr 27, 2021

- Company: [Aligos Therapeutics, Inc.](/companies/algs.md) (CIK 1799448)
- Form: DEF 14A
- Filed: 2021-04-27
- Accepted by EDGAR: Apr 27, 2021, 16:15 ET
- Period: 2021-06-17
- Accession: 0001193125-21-134253
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1799448/000119312521134253/d65632ddef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1799448/000119312521134253/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1799448/000119312521134253/d65632ddef14a.htm

Filed Apr 27, 2021.
Source: SEC EDGAR, the filing index for accession 0001193125-21-134253. Last ingested by Listed: Nov 6, 2026, 12:13 ET. No prices; not investment advice.